Notably, TNFAIP8L3, CCL14, CX3CR1, CCL21, IL1R1, and IL33 had higher expression levels in the lower-TMB subtype of at least 13 cancer types, while had higher expression levels in the higher-TMB subtype of at most 2 cancer types. This evidence concerns the gene IL33 and cancer.